Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Rigidity

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44336   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    99 result(s) found for: Rigidity. Displaying page 1 of 5.
    1  2  3  4  5  Next»
    EudraCT Number: 2007-000919-29 Sponsor Protocol Number: TB2006 Start Date*: 2006-12-20
    Sponsor Name:ISTITUTI ORTOPEDICI RIZZOLI
    Full Title: Study on reversible effect on muscle of the botulinica toxin on the prevention of the post-traumatic rigidity of elbow
    Medical condition: omero mono-Inter-sovra-sovraintercondiloidee fractures of distant them, fractures of capitello radial and fractures of olecrano with or without luxation
    Disease: Version SOC Term Classification Code Term Level
    9.1 10028330 Muscle rigidity LLT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2012-005198-30 Sponsor Protocol Number: BBHV.02-2012 Start Date*: 2013-04-30
    Sponsor Name:LAURA TARRATS VELASCO
    Full Title: EFFICACY OF ADMINISTRATION OF HYOSCINE BUTILBROMIDE (BUSCOPAN®) ON PREGNANT WOMEN IN FIRST STAGE OF LABOUR IN CASE OF CERVIX RIGIDITY. (BBH V.04-2013 EUDRACT: 2012-005198-30)
    Medical condition: in case of cervix rigidity determination in first stage of labour, pregnant women will be offered to participate and if they accept they´ll be randomised to test or control group. Placebo or treat...
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2020-000469-18 Sponsor Protocol Number: IP2018CS01 Start Date*: 2020-06-26
    Sponsor Name:Initiator Pharma
    Full Title: A Randomised, Double-Blind, Placebo-Controlled, Crossover Trial Studying the Efficacy and Safety of IP2018 in Depressed, Erectile Dysfunction (ED) Patients
    Medical condition: Male patients with a diagnosis of mild to moderate depression and ED as determined from the Hamilton depression scale score of 7 to 23 and International Index of Erectile Function (IIEF-5) score of...
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2009-009936-56 Sponsor Protocol Number: ACT10775 Start Date*: 2009-05-11
    Sponsor Name:sanofi-aventis recherche et développement
    Full Title: Randomized, double-blind, placebo and active controlled study of the activity of SAR407899A single-dose on the ability to increase duration of penile rigidity, under experimental condition, in pati...
    Medical condition: Mild to moderate erectile dysfunction
    Disease: Version SOC Term Classification Code Term Level
    11.1 10061461 LLT
    Population Age: Adults Gender: Male
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2004-005282-37 Sponsor Protocol Number: IDT.LM.LEV.22004-LEMDE Start Date*: 2005-05-24
    Sponsor Name:QUIMICA FARMACEUTICA BAYER, S.A.
    Full Title: Double-blind, cross-over, placebo-controlled pilot study to characterize the profile of those patients with traumatic spinal cord injury diagnosed by electrophysiological, urodynamic and clinical (...
    Medical condition: Erectile dysfunction (ED)
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2007-001036-31 Sponsor Protocol Number: A8361011 Start Date*: 2007-06-25
    Sponsor Name:Pfizer Limited, Ramsgate Road, Sandwich, Kent. UK. CT13 9NJ
    Full Title: A 2-COHORT, MULTI-CENTRE, RANDOMIZED, DOUBLE BLIND (3RD PARTY OPEN), PLACEBO CONTROLLED 4-WAY CROSSOVER STUDY TO ASSESS THE EFFICACY OF SINGLE ORAL DOSES OF PF-00446687 ON ERECTILE FUNCTION IN MEN ...
    Medical condition: Male erectile dysfunction (MED).
    Disease: Version SOC Term Classification Code Term Level
    9.1 10052003 Erectile dysfunction NOS LLT
    Population Age: Adults Gender: Male
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2007-001058-16 Sponsor Protocol Number: V00147GL202 Start Date*: 2007-04-30
    Sponsor Name:PIERRE FABRE MEDICAMENT
    Full Title: A PHASE II DOUBLE-BLIND VEHICLE-CONTROLLED CROSSOVER SINGLE DOSE (400 µG) V0147 GEL EFFECT AND TOLERANCE STUDY IN SPINAL CORD INJURED PATIENTS WITH ERECTILE DYSFUNCTION
    Medical condition: Erectile dysfunction
    Disease: Version SOC Term Classification Code Term Level
    21.1 10038604 - Reproductive system and breast disorders 10052004 Organic erectile dysfunction PT
    Population Age: Adults Gender: Male
    Trial protocol: FR (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2020-000033-41 Sponsor Protocol Number: AMEN1 Start Date*: 2020-02-17
    Sponsor Name:Aalborg University Hospital
    Full Title: Aciclovir for HSV-2 meningitis: A double-blind randomised controlled trial (AMEN)
    Medical condition: Viral meningitis caused by Herpes simplex virus 2
    Disease: Version SOC Term Classification Code Term Level
    21.1 100000004862 10047469 Viral meningitis LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DK (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2009-015783-34 Sponsor Protocol Number: ID 2770 Start Date*: 2009-12-23
    Sponsor Name:AZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI VERONA
    Full Title: Effects of Magnesium on Blood Pressure in Patients with familiarity for Metabolic Syndrome
    Medical condition: familiarity for matabolic syndrome
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2004-005034-39 Sponsor Protocol Number: Start Date*: 2005-05-17
    Sponsor Name:Queen Elizabeth Hospital
    Full Title: Nicotinamide,vitamin B3, metabolic pathways in patients with early idiopathic parkinson's disease
    Medical condition: Idiopathic Parkinson's disease
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2005-002216-25 Sponsor Protocol Number: PDT409 Start Date*: 2006-06-26
    Sponsor Name:Amersham Health, S.A. (filial de GE Healthcare Ltd)
    Full Title: Ensayo en fase 4 multicéntrico, aleatorizado, abierto y comparativo para evaluar las modificaciones en el manejo clínico después de una tomografía con DaTSCAN en sujetos con parkinsonismo clínicame...
    Medical condition: The subjects included in this trial will have clinically uncertain parkinsonism in a general neurologist setting.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed) IT (Completed) DK (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2007-005033-11 Sponsor Protocol Number: SRx-501-01 Start Date*: 2008-03-27
    Sponsor Name:CombinatoRx, Inc
    Full Title: A Comparison Of The Safety And Bioavailability Of Modified-Release Formulations Of Levodopa-Carbidopa In Subjects With Parkinson’s Disease
    Medical condition: Patients with Parkinson's Disease
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-006000-30 Sponsor Protocol Number: ForefootFenta vs.1 Start Date*: 2009-01-09
    Sponsor Name:Riika Merivirta
    Full Title: ”Postoperative pain treatment with fentanyl patch after forefoot surgery/ Jalkateräleikkauksen jälkeinen kivunhoito kipulaastarilla”.
    Medical condition: The patients will be recruited from 18-75 year old male or female patients undergoing hallux valgus or hallux rigidus surgery.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10019095 Hallux Valgus correction LLT
    9.1 10019092 Hallux rigidus LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: (No results available)
    EudraCT Number: 2013-000827-15 Sponsor Protocol Number: PARROT Start Date*: 2013-05-11
    Sponsor Name:Unità Malattie Neurodegenerative, Ospedale Cardinale Giovanni Panico, Tricase
    Full Title: LATE ONSET PARKINSON’S DISEASE IN SUBJECTS 70 YEARS AND OLDER: POSSIBLE USE OF ROTIGOTINE
    Medical condition: Parkinson disease
    Disease:
    Population Age: Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2014-004501-32 Sponsor Protocol Number: NL51240.018.14 Start Date*: 2014-12-11
    Sponsor Name:Academic Medical Center
    Full Title: Infusion VErsus STimulation, a cost-effectiveness analysis of the treatment in advanced Parkinson's disease comparing Continuous Intrajejunal Levodopa Infusion to the traditional standard treetment...
    Medical condition: Patients with advanced PD who's motor symptoms — severe response fluctuations, dyskinesias, painful dystonia and / or bradykinesia — cannot be controlled despite optimal oral pharmacological therapy.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2019-003962-41 Sponsor Protocol Number: 17/0909 Start Date*: 2020-03-23
    Sponsor Name:University College London
    Full Title: Trial of Ondansetron as a Parkinson’s HAllucinations Treatment
    Medical condition: Adults aged over 18 years with Parkinson's disease and visual hallucinations
    Disease: Version SOC Term Classification Code Term Level
    21.1 100000004873 10047570 Visual hallucinations LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2019-002057-34 Sponsor Protocol Number: PRePED-01 Start Date*: 2020-02-07
    Sponsor Name:Fundación de Investigación Biomédica Hospital Puerta de Hierro
    Full Title: A RANDOMISED, DOUBLE-BLIND CONTROLLED TRIAL TO EVALUATE THE EFFICACY OF INTRACAVERNOSAL INFUSION OF PLATELET RICH PLASMA (PRP) AGAINST PLATELET POOR PLASMA (PPP) IN THE TREATMENT OF VASCULOGENIC ER...
    Medical condition: Vascular Erectile Dysfunction
    Disease: Version SOC Term Classification Code Term Level
    20.0 10038604 - Reproductive system and breast disorders 10061461 Erectile dysfunction PT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2019-002046-20 Sponsor Protocol Number: FIBHGM-ECNC001-2019 Start Date*: 2020-07-22
    Sponsor Name:Fundación para la Innovación en Biomedicina-FIBMED
    Full Title: Effects of SGLT2 inhibition on the mechanisms of cardiac damage in the diabetic patient with HFpEF.-CARDIA-STIFF.
    Medical condition: Patients with Diabetes mellitus type 2 and Heart Failure with preserved Ejection Fraction.
    Disease:
    Population Age: Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-000350-31 Sponsor Protocol Number: CENA713B2315 Start Date*: 2008-01-22
    Sponsor Name:Novartis Pharma AG
    Full Title: A 76-week prospective, open-label, multicenter study to evaluate the long-term effect of Exelon® capsule and transdermal patch on worsening of the underlying motor symptoms of PD in patients with m...
    Medical condition: Mild to moderately severe dementia associated with Parkinson’s disease (PDD).
    Disease: Version SOC Term Classification Code Term Level
    9.1 10012284 Dementia due to Parkinson's disease LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed) ES (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2004-000394-60 Sponsor Protocol Number: ACR16C007 Start Date*: 2004-06-30
    Sponsor Name:A. Carlsson Research AB
    Full Title: A randomised phase II multicentre, double blind, parallel group, placebo controlled study of ACR16 50 mg once daily for the symptomatic treatment of Huntington disease
    Medical condition: ACR16 belongs to a new class of CNS active agents called dopaminergic stabilizers. Dopaminergic stabilizers are compounds that can both enhance and counteract dopamine dependent functions in the CN...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed) DK (Prematurely Ended)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Mon May 19 12:22:14 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA